The Secret Of Kcnk10 (trek-2) Rabbit Pab Limited Time 85% Off [jrA1p6IP]

KCNK10 (TREK-2) Rabbit pAb

The KCNK10 (TREK-2) Rabbit pAb is a high-quality antibody designed for researchers specializing in ion channel research. This antibody is produced using rabbit polyclonal antibodies, ensuring high specificity and affinity for the TREK-2 protein. Ideal for immunohistochemistry, immunofluorescence, and western blotting, this antibody is a valuable tool for studying the function and localization of TREK-2 in various cell types and tissues. Key features include:

• High specificity for TREK-2 protein
• Optimized for immunohistochemistry, immunofluorescence, and western blotting
• Conveniently supplied in PBS buffer

The KCNK10 (TREK-2) Rabbit pAb is carefully prepared to offer excellent performance and reproducibility. Each lot is tested for purity and activity, ensuring consistent results across experiments. The antibody is affinity-purified from rabbit serum, providing a reliable source of TREK-2-specific binding. With a molecular weight of approximately 110 kDa, this antibody is suitable for a wide range of applications. Technical specifications include:

• Reactivity: Human, Mouse, Rat
• Immunogen: Recombinant protein of TREK-2
• Concentration: 1 mg/ml

The KCNK10 (TREK-2) Rabbit pAb is an essential tool for researchers studying ion channels and their role in various physiological processes. Whether you are investigating the function of TREK-2 in neurological disorders, inflammation, or pain management, this antibody can provide valuable insights. Its high specificity and versatility make it a preferred choice for both academic and commercial research. Ideal for use in research institutions, biotech companies, and pharmaceutical organizations, this antibody is a must-have for any laboratory focused on ion channel research. Practical applications include:

• Studying TREK-2 expression and localization in various cell types and tissues
• Investigating the role of TREK-2 in neurological disorders, inflammation, and pain
• Assisting in the development of new therapeutic strategies for ion channel-related diseases